APDN Applied DNA Sciences: Operating Margin

Corporate company logo of adnas.com (APDN)

Steady demand for PCR components protects the business from inflation, however, the current operating margin on the latest GURU.Markets chart shows a level of -406.10, signaling a decline in efficiency. Management's competence in DNA synthesis and reporting transparency are rectifying the situation. The impeccable image of Applied DNA Sciences (APDN) and the trust of major B2B partners confirm its status as a leader in molecular tagging.

APDN: adnas.com Profitability of Operations 07/04/2022 - 10/07/2025

Analytical breakdowns for Applied DNA Sciences (APDN)

- price and consensus price forecast:
Comprehensive company analysis:adnas.com, APDN
Core merchandise of Applied DNA Corp

Operating margin reflects the share of profit from core business operations relative to total revenue before financial expenses and taxes, demonstrating internal cost management efficiency. An analysis of the actual operating margin allows for an assessment of Applied DNA Sciences (APDN) resilience against the expansion of low-cost RFID solutions and AI systems, where growth in this metric confirms the competitive advantage of DNA marking over alternatives.

Competitors of Applied DNA Sciences

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|Imunon Inc - Return on Sales by Operating Profit|Operating Margin PHIO (Phio Pharmaceuticals Corp)|Operating Profit Rate MBIO|RNAZ - Operating Profitability|Operating Profit Rate BNGO (bionanogenomics.com)|BLUE (Bluebird Bio) - Operating Sales Margin|ImmunoPrecise Antibodies Ltd - Operating Profit Rate|OMGA (Omega Therapeutics Inc) - Operating Margin|Operating Profitability OMIC|Operating Profitability Regulus Therapeutics Inc. (RGLS)|Operating Sales Margin Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability